Literature DB >> 29556956

Hyperactivity in mice lacking one allele of the glutamic acid decarboxylase 67 gene.

Karen Müller Smith1,2.   

Abstract

GABAergic interneuron loss, maturational delay or imbalance of glutamatergic to GABAergic signaling has been implicated in several neuropsychiatric disorders including Tourette syndrome and attention-deficit/hyperactivity disorder (ADHD). In schizophrenia, decreases in parvalbumin (PV), somatostatin (Sst) and glutamic acid decarboxylase (GAD) RNA have been observed and seem to indicate a failure in maturation in PV and Sst neurons. In Tourette syndrome, which has a high level of comorbid ADHD, reduced numbers of parvalbumin expressing neurons have been observed in the basal ganglia of affected patients. In addition, polymorphisms in the GAD1 gene that codes for GAD67 protein have been associated with ADHD. We have examined whether mice with a disrupted Gad67 allele, the Gad67 GFP knock-in mice (Gad67-GFP+/-), display abnormal locomotor behavior or altered anxiety behavior on the elevated plus maze. We found that Gad67-GFP+/- mice displayed a mild hyperactivity compared to control littermates.

Entities:  

Keywords:  ADHD; FGFR; GABA; Parvalbumin

Mesh:

Substances:

Year:  2018        PMID: 29556956      PMCID: PMC6146072          DOI: 10.1007/s12402-018-0254-0

Source DB:  PubMed          Journal:  Atten Defic Hyperact Disord        ISSN: 1866-6116


  28 in total

1.  Attention-deficit/hyperactivity disorder, self-regulation, and time: toward a more comprehensive theory.

Authors:  R A Barkley
Journal:  J Dev Behav Pediatr       Date:  1997-08       Impact factor: 2.225

Review 2.  Lighting the chandelier: new vistas for axo-axonic cells.

Authors:  Allyson Howard; Gabor Tamas; Ivan Soltesz
Journal:  Trends Neurosci       Date:  2005-06       Impact factor: 13.837

3.  A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities.

Authors:  Dan Rujescu; Andreas Bender; Martin Keck; Annette M Hartmann; Frauke Ohl; Hanna Raeder; Ina Giegling; Just Genius; Robert W McCarley; Hans-Jürgen Möller; Heinz Grunze
Journal:  Biol Psychiatry       Date:  2006-01-19       Impact factor: 13.382

4.  Neural cell adhesion molecule-secreting transgenic mice display abnormalities in GABAergic interneurons and alterations in behavior.

Authors:  Neeta Pillai-Nair; Anitha K Panicker; Ramona M Rodriguiz; Kelly L Gilmore; Galina P Demyanenko; Josh Z Huang; William C Wetsel; Patricia F Maness
Journal:  J Neurosci       Date:  2005-05-04       Impact factor: 6.167

5.  Reduced GABA concentration in attention-deficit/hyperactivity disorder.

Authors:  Richard A E Edden; Deana Crocetti; He Zhu; Donald L Gilbert; Stewart H Mostofsky
Journal:  Arch Gen Psychiatry       Date:  2012-07

6.  Deficiency in inhibitory cortical interneurons associates with hyperactivity in fibroblast growth factor receptor 1 mutant mice.

Authors:  Karen Müller Smith; Devon M Fagel; Hanna E Stevens; Rebecca L Rabenstein; Maria Elisabetta Maragnoli; Yasushi Ohkubo; Marina R Picciotto; Michael L Schwartz; Flora M Vaccarino
Journal:  Biol Psychiatry       Date:  2007-11-07       Impact factor: 13.382

7.  Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome.

Authors:  Yuko Kataoka; Paul S A Kalanithi; Heidi Grantz; Michael L Schwartz; Clifford Saper; James F Leckman; Flora M Vaccarino
Journal:  J Comp Neurol       Date:  2010-02-01       Impact factor: 3.215

8.  Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness.

Authors:  Mark O Cunningham; Jillian Hunt; Steven Middleton; Fiona E N LeBeau; Martin J Gillies; Martin G Gillies; Ceri H Davies; Peter R Maycox; Miles A Whittington; Claudia Racca
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

Review 9.  GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; Kenneth N Fish; David A Lewis
Journal:  Neural Plast       Date:  2011-09-05       Impact factor: 3.599

10.  Developmental changes in gamma-aminobutyric acid levels in attention-deficit/hyperactivity disorder.

Authors:  S Bollmann; C Ghisleni; S-S Poil; E Martin; J Ball; D Eich-Höchli; R A E Edden; P Klaver; L Michels; D Brandeis; R L O'Gorman
Journal:  Transl Psychiatry       Date:  2015-06-23       Impact factor: 6.222

View more
  5 in total

Review 1.  Neuroinflammation as a risk factor for attention deficit hyperactivity disorder.

Authors:  Geoffrey A Dunn; Joel T Nigg; Elinor L Sullivan
Journal:  Pharmacol Biochem Behav       Date:  2019-05-16       Impact factor: 3.533

2.  Global knockdown of glutamate decarboxylase 67 elicits emotional abnormality in mice.

Authors:  Shigeo Miyata; Toshikazu Kakizaki; Kazuyuki Fujihara; Hideru Obinata; Touko Hirano; Junichi Nakai; Mika Tanaka; Shigeyoshi Itohara; Masahiko Watanabe; Kenji F Tanaka; Manabu Abe; Kenji Sakimura; Yuchio Yanagawa
Journal:  Mol Brain       Date:  2021-01-07       Impact factor: 4.041

Review 3.  Investigating the Role of GABA in Neural Development and Disease Using Mice Lacking GAD67 or VGAT Genes.

Authors:  Erika Bolneo; Pak Yan S Chau; Peter G Noakes; Mark C Bellingham
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

4.  Glutamic acid decarboxylase 67 haplodeficiency in mice: consequences of postweaning social isolation on behavior and changes in brain neurochemical systems.

Authors:  Sven Nullmeier; Christoph Elmers; Wolfgang D'Hanis; Kiran Veer Kaur Sandhu; Oliver Stork; Yuchio Yanagawa; Patricia Panther; Herbert Schwegler
Journal:  Brain Struct Funct       Date:  2020-06-08       Impact factor: 3.270

5.  Vascular amyloid accumulation alters the gabaergic synapse and induces hyperactivity in a model of cerebral amyloid angiopathy.

Authors:  Pablo Cisternas; Xavier Taylor; Abigail Perkins; Orlando Maldonado; Elysabeth Allman; Ricardo Cordova; Yamil Marambio; Braulio Munoz; Taylor Pennington; Shunian Xiang; Jie Zhang; Ruben Vidal; Brady Atwood; Cristian A Lasagna-Reeves
Journal:  Aging Cell       Date:  2020-09-10       Impact factor: 11.005

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.